SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-001353
Filing Date
2023-01-20
Accepted
2023-01-20 16:42:15
Documents
5
Effectiveness Date
2023-01-20

Document Format Files

Seq Description Document Type Size
1 S-8 a032023s-8.htm S-8 79145
2 EX-FILING FEES ex107calculationoffilingfe.htm EX-FILING FEES 25167
3 EX-5.1 ex51legalopinions-8.htm EX-5.1 13474
4 EX-23.1 a231pricewaterhousecoopers.htm EX-23.1 2648
5 GRAPHIC image_1.jpg GRAPHIC 8359
  Complete submission text file 0001628280-23-001353.txt   133201
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269335 | Film No.: 23541540
SIC: 2836 Biological Products, (No Diagnostic Substances)